The American College of Cardiology and Veradigm have announced a strategic partnership create the largest ambulatory chronic disease network in the United States with more than 250,000 clinicians and 100 million patients. The partnership will integrate Veradigm’s technology and analytic capabilities with ACC’s NCDR PINNACLE Registry and Diabetes Collaborative Registry.
In addition, the integration will leverage Veradigm’s large specialist and primary care provider network on Allscripts and Practice Fusion electronic medical records (EMR) to bring ACC’s clinical guidelines, decision pathways and wealth of provider and patient engagement tools to the point of care.
Ambulatory Chronic Disease Network Benefits
The partnership will expand and enhance the value for patients, providers, health plans, researchers and other stakeholders across the health care ecosystem, while maintaining all the benefits of current participation in the PINNACLE Registry and Diabetes Collaborative Registry. Specifically, patients will have greater opportunities to participate in research studies and have increased access to evidence-based medicine and tools, while providers can expect clinical workflow solutions to be deployed more seamlessly at the point-of-care.
By leveraging registry data:
– health plans benefit from targeted interventions for disease management and population health initiatives
– life sciences researchers have access to the largest combined cardiovascular database, with over 100 million patients, for a variety of scientific studies.
To date, PINNACLE Registry and Diabetes Collaborative Registry research has been used to highlight real-world impacts of new clinical guidelines and identify where gaps in evidence-based care exist.
“ACC and Veradigm are transforming how cardiovascular and diabetes care are delivered by providing clinicians access to the right clinical information at the right time to improve the outcomes of their patients,” said Richard J. Kovacs, MD, FACC, ACC president. “As information technology transforms how we practice medicine, it is essential that we partner with the most accomplished innovators to ensure our field has full access to the fruit of technology’s progress. Our partnership with Veradigm will ensure we continue to meet our commitments to registry participants while preparing to deliver a whole new generation of clinical tools and research opportunities.”
